Peggy Sotiropoulou

Peggy Sotiropoulou

Company: T-knife Therapeutics

Job title: Chief Scientific Officer


A Next Generation TCR & Epitope Discovery Platform for the Development of Engineered TCR Therapies for Solid Tumours 11:00 am

HuTCR, an innovative platform based on complex genetic engineering, leverages natural immune processes to generate TCRs with optimal affinity and high specificity Parallel epitope discovery and TCR identification to enhance throughput and reduce discovery lead time TK-8001, a CD8 TCR-T specific for a MAGE-A1 epitope presented on HLA-A*02-01Read more

day: Day 1 - Track A - Morning

Industry Leaders’ Fireside Chat – Setting a Trailblazing Fire to the Cell Therapy Field with Next Generation Approaches 9:00 am

An executive panel discussion from the industry leaders of the field to set the scene on next generation CAR-TCR therapies. Ask your questions live to understand the expert’s thoughts on key topics including: Successes and hurdles to date: T-cell therapy translation to solid tumours, non-oncologic disorders and off-the-shelf (ex vivo and in vivo) T-cell engineering…Read more

day: Day One

Chair’s Opening Remarks 8:20 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.